Glipizide is used for: Type 2 DM.
Recorded in the NepalDoc medicine catalog for Glipizide.
Glipizide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
From the U.S. FDA-approved label for Glipizide. Full label: DailyMed.
Glipizide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
From the U.S. FDA-approved label for Glipizide. Full label: DailyMed.
There is no fixed dosage regimen for the management of diabetes mellitus with glipizide or any other hypoglycemic agent. In addition to the usual monitoring of urinary glucose, the patient’s blood glucose must also be monitored periodically to determine the minimum effective dose for the patient; to detect primary failure, i.e., inadequate lowering of blood glucose at the maximum recommended dose of medication; and to detect secondary failure, i.e., loss of an adequate blood-glucose-lowering response after an initial period of effectiveness.
Directions from the U.S. FDA-approved label for Glipizide — your doctor or pharmacist may advise differently.
Glipizide tablets are contraindicated in patients with: 1. Known hypersensitivity to the drug. Type 1 diabetes mellitus, diabetic ketoacidosis, with or without coma. This condition should be treated with insulin.
Excerpt from the U.S. FDA-approved label for Glipizide. Talk to a pharmacist or doctor before use.
SPECIAL WARNING ON INCREASED RISK OF CARDIOVASCULAR MORTALITY: The administration of oral hypoglycemic drugs has been reported to be associated with increased cardiovascular mortality as compared to treatment with diet alone or diet plus insulin. This warning is based on the study conducted by the University Group Diabetes Program (UGDP), a long-term prospective clinical trial designed to evaluate the effectiveness of glucose-lowering drugs in preventing or delaying vascular complications in patients with non-insulin-dependent diabetes.
Warnings and precautions excerpt from the U.S. FDA-approved label for Glipizide — not a complete list. Talk to a pharmacist or doctor before use.
In U.S. and foreign controlled studies, the frequency of serious adverse reactions reported was very low. Of 702 patients, 11.8% reported adverse reactions and in only 1.5% was glipizide discontinued. Hypoglycemia: See Error! Hyperlink reference not valid. and Error! Hyperlink reference not valid. sections. Gastrointestinal: Gastrointestinal disturbances are the most common reactions.
Excerpt from the U.S. FDA-approved label for Glipizide — not a complete list. Talk to a pharmacist or doctor about side effects.
9 brands · 8 makers in the NepalDoc catalog — see the full Glipizide guide →
Store below 30°C (86°F). Keep this and all medication out of the reach of children.
Storage information from the U.S. FDA-approved label for Glipizide.
What is Gpz?
Gpz 5mg Tablet is a Glipizide medicine made by Apex Pharmaceuticals Pvt. Ltd. It comes as 5mg Tablet.
What is Gpz used for?
Glipizide is used for Type 2 DM.
What is the generic name of Gpz?
The generic name of Gpz is Glipizide.
Which brands of Glipizide are available in Nepal?
9 brands of Glipizide are listed in the NepalDoc catalog, from 8 makers — including Dibizide 5mg Tablet, Glez 5mg Tablet, Glez 2.5 mg Tablet, Glide 5mg Tablet, Glipiz 5mg Tablet, Glipy 5mg Tablet.
What are the side effects of Glipizide?
In U.S. and foreign controlled studies, the frequency of serious adverse reactions reported was very low. Of 702 patients, 11.8% reported adverse reactions and in only 1.5% was glipizide discontinued. Hypoglycemia: See Error!
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
